Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
Psychological Medicine
|
April 13, 2026
Cost-utility and cost-effectiveness of SELFIE, a transdiagnostic ecological momentary intervention for improving self-esteem in youth aged 12-26 years exposed to childhood adversity: Findings from a multicenter randomized controlled trial
Anouk Boonstra, Maud Daemen, Sander Osstyn, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 6, 2019
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype
Lisa Vermunt, Sietske A M Sikkes, Ardo van den Hout, et al.
The Journal of Prevention of Alzheimer'S Disease
|
January 12, 2025
Informal care for people with dementia in Europe
Ron Handels, Somboon Hataiyusuk, Anders Wimo, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
October 17, 2020
Obtaining EQ-5D-5L utilities from the disease specific quality of life Alzheimer's disease scale: development and results from a mapping study
Ines Rombach, Marvi Iftikhar, Gurleen S Jhuti, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
March 26, 2017
Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia
Anja Hviid Simonsen, Sanna-Kaisa Herukka, Niels Andreasen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
March 26, 2017
Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment
Sanna-Kaisa Herukka, Anja Hviid Simonsen, Niels Andreasen, et al.
BMJ Open
|
June 10, 2021
Prevention of dementia using mobile phone applications (PRODEMOS): protocol for an international randomised controlled trial
Esmé Eggink, Melanie Hafdi, Marieke P Hoevenaar-Blom, et al.
JAMA Network Open
|
January 22, 2025
Cerebral Microbleeds and Amyloid Pathology Estimates From the Amyloid Biomarker Study
Julie E Oomens, Veerle van Gils, Stephanie J B Vos, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
October 28, 2017
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
Piotr Lewczuk, Peter Riederer, Sid E O'Bryant, et al.
Journal of Alzheimer'S Disease : JAD
|
November 14, 2025
Associations of lifestyle factors with amyloid pathology in persons without dementia
Julie E Oomens, Stephanie Jb Vos, Nancy N Maserejian, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
Psychological Medicine
|
April 13, 2026
Cost-utility and cost-effectiveness of SELFIE, a transdiagnostic ecological momentary intervention for improving self-esteem in youth aged 12-26 years exposed to childhood adversity: Findings from a multicenter randomized controlled trial
Anouk Boonstra, Maud Daemen, Sander Osstyn, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 6, 2019
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype
Lisa Vermunt, Sietske A M Sikkes, Ardo van den Hout, et al.
The Journal of Prevention of Alzheimer'S Disease
|
January 12, 2025
Informal care for people with dementia in Europe
Ron Handels, Somboon Hataiyusuk, Anders Wimo, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
October 17, 2020
Obtaining EQ-5D-5L utilities from the disease specific quality of life Alzheimer's disease scale: development and results from a mapping study
Ines Rombach, Marvi Iftikhar, Gurleen S Jhuti, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
March 26, 2017
Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia
Anja Hviid Simonsen, Sanna-Kaisa Herukka, Niels Andreasen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
March 26, 2017
Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment
Sanna-Kaisa Herukka, Anja Hviid Simonsen, Niels Andreasen, et al.
BMJ Open
|
June 10, 2021
Prevention of dementia using mobile phone applications (PRODEMOS): protocol for an international randomised controlled trial
Esmé Eggink, Melanie Hafdi, Marieke P Hoevenaar-Blom, et al.
JAMA Network Open
|
January 22, 2025
Cerebral Microbleeds and Amyloid Pathology Estimates From the Amyloid Biomarker Study
Julie E Oomens, Veerle van Gils, Stephanie J B Vos, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
October 28, 2017
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
Piotr Lewczuk, Peter Riederer, Sid E O'Bryant, et al.
Journal of Alzheimer'S Disease : JAD
|
November 14, 2025
Associations of lifestyle factors with amyloid pathology in persons without dementia
Julie E Oomens, Stephanie Jb Vos, Nancy N Maserejian, et al.
Page
of 7